Active	Status	Sponsor type	Region	Phase	Filter
19 Active 7 Inactive 26 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sun, Xin
NCT05092841: A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A	Completed	3	176	RoW	PXT3003, (RS)-baclofen, naltrexone hydrochloride and D-sorbitol oral fixed dose combination, PXT3003 placebo, liquid oral solution	Tasly GeneNet Pharmaceuticals Co., Ltd	Charcot-Marie-Tooth Type 1A	03/24	03/24
NCT05944224: A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.	Recruiting	1/2	63	RoW	SPH4336, Cadonilimab	Shanghai Pharmaceuticals Holding Co., Ltd	Advanced Solid Tumors	05/25	12/25